Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 - A case series.

Transfus Apher Sci · 2021 · PMC8447834 · PMID 34548246

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Available PVPI levels were divergent prior to CPT (B-cell-depleted: 2.4 and 4.7, versus control: 5.7 and 2.5) but decreased in B-cell-depleted patients (1.9 and 4.2) in contrast to an increasing trend in control patients following CPT (2.9–5.8).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.